Press Releases Archives - Page 7 of 103 - Lupin

BSE 2300.00 NSE 2307.90

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2300.00 NSE 2307.90

Lupin Launches Eslicarbazepine Acetate Tablets in the United States

Lupin Receives Approval from U.S. FDA for Tolvaptan Tablets

Lupin Diagnostics Achieves NABL Accreditation for All Greenfield Labs

Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur

Lupin Announces the Acquisition of Renascience in the United Kingdom

Lupin Foundation Organizes State-Level Workshop to Enhance Healthcare Systems in Rajasthan

Lupin Digital Health Introduces Comprehensive Post-Procedure Home-Based Care Guide in Collaboration with the American College of Cardiology

Nanomi Receives CMO Award for Life Science Leadership in Drug Delivery

Lupin Awarded EcoVadis Silver Medal for Sustainability Excellence, Ranks Among the Top 15% Globally

Lupin Receives Tentative Approval from U.S. FDA for Amifampridine Tablets

1 2 … 6 7 8 … 102 103

Search

Hit enter to search or ESC to close